skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Can I get your thoughts on the recent announcement of "Intrinsyc’s engagement of Roth Capital Partners, LLC (“Roth”) as a financial advisor with a mandate to accelerate strategic growth opportunities for the Company. The goal of Roth’s mandate, which has been documented by a formal engagement agreement on standard industry terms, is to enhance value for all holders of Intrinsyc common shares."

Thanks
Read Answer Asked by Scott on February 11, 2019
Q: Hi team,

I don't see any questions on this company Cardiol Therapeutics Inc. (CRDL) that did a recent IPO on TSX and hit a 52 week high today. It seems they are in a (speculative) cannabinoid arena with some drugs coming into phase 1 stages in 2019.
What is management history (CEO, CFO, etc.), board of directors, ...ie are they a solid team?
They had a string of announcements (LOI's, exclusive agreements, etc) in 2017 but no real follow-up news in 2018 wrt these signings.
Does their product pipeline seem promising?
How might it compare to Cannimed wrt therapeutic applications?

Is it a company to just watch for now given it's very recent IPO? So many IPO's flop in the first 6 months thus the caution.

Appreciate your insight!

Cheers,
SteveMc
Read Answer Asked by Stephen on February 06, 2019
Q: Greetings 5i crew,
If one were interested in investing in the graphene industry where would you suggest we park some capital to do so?
One company came on my radar called Graphene Nanochem symbol GRPEF. Unfortunately cannot find enough information on it to make an educated decision upon. Any info would be much appreciated. http://www.graphenenanochem.com/

Cheers
Stew
Read Answer Asked by Alex on February 05, 2019